Video

Unlocking the Potential of Underutilized Gene Delivery Platforms in Cancer and Beyond

Source: Cell & Gene

In this Cell & Gene Live, Advancing Gene Delivery: LNPs, Adenovirus, Lentivirus, And More, Francesca Barone, M.D., Ph.D., CSO at Candel Therapeutics highlights renewed industry interest in intratumoral delivery, especially for oncolytic therapies, while Dr. Kozarsky underscores the growing promise of in vivo lentiviral applications. Together, they explore scientific and commercial strategies needed to fully realize the impact of these platforms in gene therapy.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)